Robert Anthony Williamson

This inventor holds 13 USPTO granted patents, plus 3 CIPO patents and 1 EPO patent. Top assignees: Janssen Vaccines & Prevention B.v., Crucell Holland B.v., Ribovax Biotechnologies S.a.. Active years: 2013-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Anthony Williamson. Retrieved from https://idiyas.com/inventor/robert-anthony-williamson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 46.2

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 54(Granted Patents)

Location History:

La Jolla, CA (US) (2013 - 2016)
London, GB (2016 - 2019)
Leiden, NL (2019 - 2022)

Company Filing History:

8 out of 117

Janssen Vaccines & Prevention B.v.

Ribovax Biotechnologies S.a.

patents

Years Active: 2013-2022

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11472869 - Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau (2022-10-18),

2. 10562963 - Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau (2020-02-18),

3. 10517941 - Influenza virus vaccines and uses thereof (2019-12-31),

4. 10400034 - Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau (2019-09-03),

5. 10301379 - Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau (2019-05-28),

6. 10196438 - Human antibodies binding to RSV G protein (2019-02-05),

7. 10035842 - Human antibodies binding to RSV G proteins (2018-07-31),

8. 9988437 - Anti-human Respiratory Syncytial Virus (RSV) antibodies and methods of use (2018-06-05),

9. 9403900 - Anti-human respiratory syncytial virus (RSV) antibodies and methods of use (2016-08-02),

10. 9365638 - Antibodies against human respiratory syncytial virus (RSV) and methods of use (2016-06-14),

11. 9139642 - Anti-human respiratory syncytial virus (RSV) antibodies and methods of use (2015-09-22),

12. 8747856 - Antigen binding fragments of an antibody for use in treating or diagnosing ocular diseases (2014-06-10),

13. 8568719 - Antibodies against human respiratory syncytial virus (RSV) and methods of use (2013-10-29),

Title: Robert Anthony Williamson - Pioneering Inventor from London, GB

Introduction: Robert Anthony Williamson is a distinguished inventor based in London, GB, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Robert Anthony Williamson holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Robert Anthony Williamson has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing solutions that push the boundaries of conventional thinking.

Collaborations: Throughout his career, Robert Anthony Williamson has collaborated with leading research institutions, universities, and companies to bring his inventions to life, fostering a culture of innovation and excellence in the industry.

Conclusion: Robert Anthony Williamson's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazing inventor, inspiring the next generation of inventors to think boldly and create fearlessly.

Profile summary based on public USPTO records.